Hematopoietic stem cell transplantation. Experience at the Centro Médico Nacional de Occidente;Trasplante de células hematopoyéticas. Experiencia del Centro Médico Nacional de Occidente

Revista de Investigacion Clinica

Volumn 52, Issue 3, 2000, Pages 234-240

  Delgado Lamas, José Luis ^a,b   Garcés Ruiz, Óscar Miguel ^a   Rubio Jurado, Benjamín ^a  

^a Hosp Especialidades Ctro Medico N   (Mexico)

^b Colonia Oblatos Independencia ^*  (Mexico)

Author keywords

Bone marrow transplantation; Stem cell peripheral blood transplant; Third level attention

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MIDDLE AGED;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED;

EID: 0344323582     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. León-Rodríguez E. Transplante de médula ósea alogénica. Rev Inv Clin (Méx.) 1993; 45: 77-84.
2. Clark J.G. The challenge of bone marrow transplantation. Mayo Clin Proc 1990; 65: 111-14.
3. Champlin R. Bone marrow transplantation, introduction and overview. In: Bone marrow transplantation. Ed. Champlin R. Kluwer Academic Publisher 1990; 1-7.
4. Bathia R. Forman SJ. Autologous transplantation for the treatment of chronic myelogenous leukemia. Hemato-Oncol Clin North Am 1998; 12: 151-72.
5. Carreras E, Sierra J, Montserrat R, Urbano-Ipizua A, Martínez C, Nomdedeu B et al. Successful autografting in chronic myelogenous leukemia using Philadelphia negative blood progenitor cells mobilized with rHuG-CSF alone in a patient responding to alpha interferon. Brit J Haematol 1997; 96: 421-23.
6. Pratt G, Johnson RJ, Rawstron AC, Barnard DL, Morgan GJ, Smith GM. Autologous stem cell transplantation in chronic myeloid leukemia using a Philadelphia chromosome negative blood progenitors mobilized with hidroxyurea and G-CSF. Bone Marrow Transplant. 1998; 21: 455-460.
7. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Larregina-Diez A, Apreza-Molina MG. Filgrastim mobilized peripheral blood stem cell can be stored at 4 degrees and used in autografts to rescue high dose chemotherapy. Am J Hematol 1995; 48: 100-3.
8. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral blood stem cell transplantation restores hemopoietic function marrow following ablative chemotherapy. Blood 1988; 71: 723-7.
9. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
10. Gómez-Almaguer D, Ruiz-Argüelles GJ, Piñeiro LA, Ruiz-Argüelles A. Trasplante heterólogo de células hematopoyéticas de sangre periférica. Informe de dos casos. Rev Inv Clín (Méx.) 1997; 49: 41-45.
11. Ruiz-Argüelles JG. Criopreservación, conservación a 4° y reducción de costos en el autotrasplante de células precursoras hematopoyéticas. Sangre 1995; 40: 78.
12. González-Llavén J, Sánchez-Cortés E. Costos del tratamiento de la leucemia aguda. XXXVIII Jornada Anual de la Agrupación Mexicana para el Estudio de la Hematología. Rev Inv Clin Suppl. Mayo, 1997.
13. Dipp-Kuri A. Registro Nacional de Trasplantes. Informe Anual SSA. 1998.
14. Gorin N.C. Autologous stem cell transplantation in acute myeloblastic leukemia. Blood 1998; 92: 1073-90.
15. Ruiz-Argüelles GJ, Lobato-Mendizabal E, Ruiz-Argüelles A, Pérez-Romano B, Arizpe-Bravo D, Marín-López A. Long-term results of a non-cryopreserved unmanipulated hematopoietic peripheral blood stem cell autotrasplant program. Arch Med Res 1999. En prensa.
16. León RE, Sosa SR, Hurtado MR, Sanchez GS, Gomez GE, López-Karpovitch X et al. Trasplante de células hematopoyéticas en padecimientos hematológicos. Experiencia del Instituto Nacional de la Nutrición SZ (1987-1997) Cartel 99. XL Jornada Anual de la Agrupación Mexicana para el Estudio de la Hematología, Tuxtla Gutiérrez, Chiapas. 23 al 27 de Abril de 1999.
17. Tripp VF, Vela OJ, Sánchez E, Ayala M, García L, González-Llavén J. Autotrasplante para enfermedad de Hodgkin y linfoma no Hodgkin. Presentación Oral No-59. XL Jornada Anual de la Agrupación Mexicana para el Estudio de la Hematología. Tuxtla Gutiérrez, Chiapas. 23 al 27 de Abril de 1999.
18. Cassileth PA, Harrington DP, Appelbaum RF, Lazarus MH, Rowe MJ, Paietta E et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 1998; 339: 1649-1656.
19. Zitoun RA, Mandelli F, Willemze R et al. Autologous bone marrow transplantation in acute myeloid leukemia in first remission. J Clin Oncol 1993; 11: 314-9.
20. Burnett AK, Goldstone AH, Stevens RMF. Randomized comparison of addition of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukemia in first remission: results of MRC AML 10 trial. Lancet 1998; 351: 700-8.
21. Harousseau JL, Cahn JY, Pignon B et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. Blood 1997; 90: 2978-86.
22. Kantarjian HM, Smith T, Obrien S, Beran M, Pierce S, Talpaz M. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-α 2 therapy. Ann Intern Med 1995; 122: 254-261.
23. Cortés J, Talpaz M, O Brien S, Rios MB, Majlis A, Keating M, Freireich EJ, Kantarjian H. Suppression of cytogenetic clonal evolution with interferon alpha therapy in patients with Philadelphia chromosome positive chronic myelogenous leukemia. J Clin Oncol 1998; 16: 3279-3285.
24. Gale RP, Hehlmann R, Zhang M-J, Hasford J, Goldman JM, Heimpel HJR. Survival with bone marrow transplantation versus hidroxyurea or interferon for chronic myelogenous leukemia. Blood 1998; 91: 1810-5.
25. González-Llavén J, Tripp V F, Vela OJ, Sánchez E. Análisis de los resultados y las tendencias de un programa de referencia nacional de trasplante de médula ósea. Cartel 29. XXXVIII Jornada Anual de la Agrupación Mexicana para el Estudio de la Hematología. La Rev Inv Clin Suppl. Mayo, 1997.
26. Appelbaum FR Clift R, Radich J, Anasetti C, Buckner CD. Bone marrow transplantation for chronic myelogenous leukemia. Semin Oncol 1995; 22: 405-15.
27. Ching HP, Evans EW. Acute lymphoblastic leukemia. Review article. N Engl J Med 1998; 339: 605-15.
28. Forman JS. Role of cytogenetics in stem cells transplantation for adult patients with acute leukemia. Education Program Book. American Society of Hematology. Miami Fl. 1998: 353-7.
29. Carey PJ, Proctor SJ, Taylor P, Hamilton PJ. Autologous bone marrow transplantation for high grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. Blood 1991; 77: 1593-8.
30. Faber L, Vander Hoeven J, Goulmy E. Recognition of clonogenic leukemic cells, remission bone marrow and HLA identical bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific citotoxic T lymphocytes. J Clin Invest 1995; 96: 877-879.
31. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-1577.
32. Negrin R, Storb R-, Forman S. Bone marrow transplantation in malignant disease. Education Program Book. American Society of Hematology. Miami, Fl. 1998. 342-370.
33. Gómez-Almaguer D, Ruiz-Argüelles JG, Ruiz-Argüelles A. González-Llano O, Cantú OE, Hernández NE. Hematopoietic stem cell allografts using a non myeloablative conditioning regimen can be safely performed on an outpatient basis. Bone Marrow Transpl. En prensa.
34. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Delgado-Lamas JL. Non-cryopreserved peripheral blood stem cell autotransplants for hematological malignancies can be performed entirely on an outpatients basis. Am J Hematol 1998; 58: 161-164.